However, there are also reports that increased expression of CCL2 in tumor tissue is associated with better prognosis: These studies include patients with gastric cancer [59], colorectal cancer [76], liver cancer [77], and non-small cell lung cancer [78]. The gene discussed is CCL2; the disease is non-small cell lung carcinoma.